Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 115

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 7
Chunk 115
---
312024 vs. 20232023 vs. 2022 202420232022$%$%Total operating revenue$175,204 $170,209 $155,660 $4,995 2.9 %$14,549 9.3 %Net investment income2,051 1,825 1,485 226 12.4 %340 22.9 %Net losses on financial instruments(445)(694)(550)249 (35.9)%(144)26.2 %Gain on sales of business201 — — 201 100.0 %— — %Total revenues177,011 171,340 156,595 5,671 3.3 %14,745 9.4 %Benefit expense127,567 124,330 116,642 3,237 2.6 %7,688 6.6 %Cost of products sold19,750 17,293 13,035 2,457 14.2 %4,258 32.7 %Operating expense20,025 20,087 17,700 (62)(0.3)%2,387 13.5 %Other expense1 1,765 1,915 1,618 (150)(7.8)%297 18.4 %Total expenses169,107 163,625 148,995 5,482 3.4 %14,630 9.8 %Income before income tax expense 7,904 7,715 7,600 189 2.4 %115 1.5 %Income tax expense1,933 1,724 1,712 209 12.1 %12 0.7 %Net income5,971 5,991 5,888 (20)(0.3)%103 1.7 %Net loss (gain) attributable to noncontrolling interests 9 (4)6 13 NM(10)NMShareholders’ net income$5,980 $5,987 $5,894 $(7)(0.1)%$93 1.6 %Average diluted shares outstanding232.9 237.4 242.8 (4.5)(1.9)%(5.4)(2.